The efficacy of green light laser prostatectomy in the management of urinary retention due to prostate hyperplasia


To evaluate the efficacy and safety of 120 W potassium titanyl phosphate (KTP) in the treatment of urinary retention (UR) due to benign prostate hyperplasia in high-risk patients. Forty-six male patients with mean age of 73.78 ± 9.82 years who اhad UR and underwent 120 W KTP laser vaporization of the prostate between January 2015 and June 2017 were included. We evaluated perioperative parameters including serum prostate specific antigen, prostate volume, period of postoperative catheterization, vaporization time, delivered energy, hospitalization period, as well as intraoperative and postoperative complications. In the follow-up protocols, International Prostate Symptom Score and quality-of-life questionnaire (IPPS-QoL) and postvoid residual volume (PVR) were also assessed. The mean follow-up period was 15.57 ± 9.26 (1–42) months. All patients get rid of UR, except 1 patient (2.1%) remained on Foley catheter and standard TURP was done. Mean vaporization time was 8.57 ± 4.19 min, and mean energy delivered was 51.7 ± 29.9 kJ. No intraoperative complications were observed and no blood transfusion was done. The mean postoperative IPSS at the last follow-up was 9.64 ± 6.65 and the QoL score was 1.61 ± 1.31. Green light laser prostatectomy is a safe, simple, and effective procedure for the treatment of UR secondary to BPH in high-risk patients. Short hospitalization, low rate of intra operative and postoperative complications with rapid improvements in the objective, and subjective voiding parameters are important considerations of this procedure.

This is a preview of subscription content, log in to check access.


  1. 1.

    Cantlay A, Ni Raghallaigh H (2015) Benign prostatic hyperplasia. Innov AiT 8(4):238–245

    Google Scholar 

  2. 2.

    Bachmann A, Tubaro A, Barber N, d’Ancona F, Muir G, Witzsch U, Grimm MO, Benejam J, Stolzenburg JU, Riddick A, Pahernik S (2014) 180-W XPS GreenLight laser vaporisation versus transurethral resection of the prostate for the treatment of benign prostatic obstruction: 6-month safety and efficacy results of a European Multicentre Randomised Trial—the GOLIATH study. Eur Urol 65(5):931–942

    PubMed  Article  Google Scholar 

  3. 3.

    Malek RS, Barrett DM, Kuntzman RS (1998) High-power potassium-titanyl-phosphate (KTP/532) laser vaporization prostatectomy: 24 hours later. Urology 51(2):254–256

    CAS  PubMed  Article  Google Scholar 

  4. 4.

    Nair SM, Pimentel MA, Gilling PJ (2016) A review of laser treatment for symptomatic BPH (benign prostatic hyperplasia). Curr Urol Rep 17(6):45

    PubMed  Article  Google Scholar 

  5. 5.

    Ahyai SA, Gilling P, Kaplan SA, Kuntz RM, Madersbacher S, Montorsi F, Speakman MJ, Stief CG (2010) Meta-analysis of functional outcomes and complications following transurethral procedures for lower urinary tract symptoms resulting from benign prostatic enlargement. Eur Urol 58(3):384–397

    PubMed  Article  Google Scholar 

  6. 6.

    Thangasamy IA, Chalasani V, Bachmann A, Woo HH (2012) Photoselective vaporisation of the prostate using 80-W and 120-W laser versus transurethral resection of the prostate for benign prostatic hyperplasia: a systematic review with meta-analysis from 2002 to 2012. Eur Urol 62(2):315–323

    PubMed  Article  Google Scholar 

  7. 7.

    Alivizatos G, Skolarikos A, Chalikopoulos D, Papachristou C, Sopilidis O, Dellis A, Kastriotis I, Deliveliotis C (2008) Transurethral photoselective vaporization versus transvesical open enucleation for prostatic adenomas> 80 ml: 12-mo results of a randomized prospective study. Eur Urol 54(2):427–437

    PubMed  Article  Google Scholar 

  8. 8.

    Bachmann A, Muir GH, Collins EJ, Choi BB, Tabatabaei S, Reich OM, Gomez-Sancha F, Woo HH (2012) 180-W XPS GreenLight laser therapy for benign prostate hyperplasia: early safety, efficacy, and perioperative outcome after 201 procedures. Eur Urol 61(3):600–607

    PubMed  Article  Google Scholar 

  9. 9.

    Ruszat R, Seitz M, Wyler SF, Abe C, Rieken M, Reich O, Gasser TC, Bachmann A (2008) GreenLight laser vaporization of the prostate: single-center experience and long-term results after 500 procedures. Eur Urol 54(4):893–901

    PubMed  Article  Google Scholar 

  10. 10.

    Horasanli K, Silay MS, Altay B, Tanriverdi O, Sarica K, Miroglu C (2008) Photoselective potassium titanyl phosphate (KTP) laser vaporization versus transurethral resection of the prostate for prostates larger than 70 mL: a short-term prospective randomized trial. Urology 71(2):247–251

    PubMed  Article  Google Scholar 

  11. 11.

    Meskawi M, Hueber PA, Valdivieso R, Bruyere F, Misrai V, Fournier G, Munver R, Sivarajan G, Rutman M, Te AE, Chughtai B (2017) Multicenter international experience of 532 nm-laser photo-vaporization with Greenlight XPS in men with large prostates (prostate volume> 100 cc). World J Urol 35(10):1603–1609

    PubMed  Article  Google Scholar 

  12. 12.

    Bachmann A, Tubaro A, Barber N, d’Ancona F, Muir G, Witzsch U, Grimm MO, Benejam J, Stolzenburg JU, Riddick A, Pahernik S (2015) A European multicenter randomized noninferiority trial comparing 180 W GreenLight XPS laser vaporization and transurethral resection of the prostate for the treatment of benign prostatic obstruction: 12-month results of the GOLIATH study. J Urol 193(2):570–578

    PubMed  Article  Google Scholar 

  13. 13.

    Valdivieso R, Meyer CP, Hueber PA, Meskawi M, Alenizi AM, Azizi M, Trinh QD, Misrai V, Rutman M, Te AE, Chughtai B (2016) Assessment of energy density usage during 180W lithium triborate laser photoselective vaporization of the prostate for benign prostatic hyperplasia. Is there an optimum amount of kilo-Joules per gram of prostate? BJU Int 118(4):633–640

    CAS  PubMed  Article  Google Scholar 

  14. 14.

    Mitropoulos D, Artibani W, Graefen M, Remzi M, Rouprêt M, Truss M (2012) Reporting and grading of complications after urologic surgical procedures: an ad hoc EAU guidelines panel assessment and recommendations. Eur Urol 61(2):341–349

    PubMed  Article  Google Scholar 

  15. 15.

    Gratzke C, Bachmann A, Descazeaud A, Drake MJ, Madersbacher S, Mamoulakis C, Oelke M, Tikkinen KA, Gravas S (2015) EAU guidelines on the assessment of non-neurogenic male lower urinary tract symptoms including benign prostatic obstruction. Eur Urol 67(6):1099–1109

    PubMed  Article  Google Scholar 

  16. 16.

    McVary KT, Roehrborn CG, Avins AL, Barry MJ, Bruskewitz RC, Donnell RF, Foster HE, Gonzalez CM, Kaplan SA, Penson DF, Ulchaker JC (2011) Update on AUA guideline on the management of benign prostatic hyperplasia. J Urol 185(5):1793–1803

    PubMed  Article  Google Scholar 

  17. 17.

    Robert G, Cornu JN, Fourmarier M, Saussine C, Descazeaud A, Azzouzi AR, Vicaut E, Lukacs B (2016) Multicentre prospective evaluation of the learning curve of holmium laser enucleation of the prostate (HoLEP). BJU Int 117(3):495–499

    PubMed  Article  Google Scholar 

  18. 18.

    Altay B, Erkurt B, Kiremit MC, Guzelburc V, Boz MY, Albayrak S (2015) 180-W XPS GreenLight laser vaporization for benign prostate hyperplasia: 12-month safety and efficacy results for glands larger than 80 mL. Lasers Med Sci 30(1):317–323

    PubMed  Article  Google Scholar 

  19. 19.

    Bouchier-Hayes DM, Van Appledorn S, Bugeja P, Crowe H, Challacombe B, Costello AJ (2010) A randomized trial of photoselective vaporization of the prostate using the 80-W potassium-titanyl-phosphate laser vs transurethral prostatectomy, with a 1-year follow-up. BJU Int 105(7):964–969

    PubMed  Article  Google Scholar 

  20. 20.

    Ahmed HU, Thwaini A, Shergill IS, Hammadeh MY, Arya M, Kaisary AV (2007) Greenlight prostatectomy: a challenge to the gold standard?: a review of KTP photoselective vaporization of the prostate. Surg Laparosc Endosc Percutan Tech 17(3):156–163

    PubMed  Article  Google Scholar 

  21. 21.

    Spaliviero M, Strom KH, Gu X, Araki M, Culkin DJ, Wong C (2010) Does Greenlight HPS™ laser photoselective vaporization prostatectomy affect sexual function? J Endourol 24(12):2051–2057

    PubMed  Article  Google Scholar 

  22. 22.

    Malek RS, Kuntzman RS, Barrett DM (2005) Photoselective potassium-titanyl-phosphate laser vaporization of the benign obstructive prostate: observations on long-term outcomes. J Urol 174(4):1344–1348

    PubMed  Article  Google Scholar 

Download references

Author information



Corresponding author

Correspondence to Mahmoud Mustafa.

Ethics declarations

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Conflict of interest

The authors declare that there is no conflict of interest.

Informed consent

The study was retrospective; therefore, no need for informed consent to be obtained from the patients.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Mustafa, M., Sowedy, A., Nashrati, O. et al. The efficacy of green light laser prostatectomy in the management of urinary retention due to prostate hyperplasia. Lasers Med Sci 34, 1201–1205 (2019).

Download citation


  • Prostate
  • Green light laser
  • BPH